The bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.
The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.
The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of indication, the jaundice segment was the major shareholder in 2023.
As per age group, neonatal emerged as the leading segment in 2023.
Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.
Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Bilirubin meter is a handheld medical device designed to measure the levels of bilirubin in the blood, primarily in newborns. Elevated bilirubin levels can lead to jaundice, a common condition in infants that, if left untreated, can cause serious health issues, including brain damage. These meters provide a non-invasive, quick, and accurate method for monitoring bilirubin levels, enabling early detection and treatment. Thus, they play a critical role in neonatal care, helping healthcare professionals make informed decisions about the need for further testing or interventions.
The growth of the global bilirubin meters market is driven by alarming rise in prevalence of neonatal jaundice and increase in emphasis on early diagnosis and treatment of jaundice in newborns to prevent complications such as kernicterus. According to a study published by Science Direct in January 2024, approximately 1.1 million babies worldwide develop hyperbilirubinemia yearly; over 20 million are at risk of hyperbilirubinemia-related complications. Furthermore, rise in the number of preterm births, which are more susceptible to jaundice, is contributing to the demand for bilirubin meters. This is attributed to the fact that premature infants often require closer monitoring, making bilirubin meters essential in neonatal intensive care units. As per the World Health Organization, approximately 13.4 million preterm births were reported in 2020. Furthermore, rise in government initiatives aimed at reducing infant mortality and improving neonatal health is encouraging the adoption of bilirubin meters, which acts as the key driving force of the global market. Shift toward non-invasive bilirubin meters, which measure bilirubin levels through the skin using transcutaneous methods, is the current trend that is strengthening the growth of the global market. These devices reduce the need for blood draws, making the process less stressful for newborns and more efficient for healthcare providers. Although non-invasive and digital bilirubin meters offer significant benefits, their high cost can be a barrier to adoption, particularly in low-income regions and smaller healthcare facilities, thereby hampering the market growth. In addition, lack of awareness and training among healthcare providers regarding the importance of regular bilirubin monitoring and the use of bilirubin meters acts as a key deterrent factor of the market. On the contrary, manufacturers are focusing on the development of portable and point-of-care bilirubin meters, which are compact, easy to use, and designed for use in various settings, including hospitals, clinics, and even in-home care. Furthermore, innovations in sensor technology are leading to more accurate and reliable bilirubin meters. These advancements include the use of multispectral sensors and algorithms that provide precise measurements, even in infants with darker skin tones, addressing previous limitations of older devices. Such developments are expected to offer lucrative opportunities for the market growth.
The global bilirubin meters industry is segmented into product, indication, age group, end user, and region. By product, the market is divided into bench-top and transcutaneous. On the basis of indication, it is segregated into jaundice and hepatitis. As per age group, it is classified into neonatal and adults. Depending on end user, it is segregated into hospitals & nursing home, clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the transcutaneous segment dominated the market share in 2023.On the basis of indication, the jaundice segment was the major shareholder in 2023.
As per age group, neonatal emerged as the leading segment in 2023.
Depending on end user, hospitals & nursing home emerged as the leading segment in 2023.
Region wise, North America garnered maximum share in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bilirubin meters market include APEL Co. Ltd., Dragerwerk AG & Co. KGaA, Mennen Medical Ltd, Micro Lab Instruments, Ningbo David Medical Device Co. Ltd., Siemens Healthineers AG, Micro Labs Instruments, AVI Healthcare Pvt Ltd, F. Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
By Product
- Bench-Top
- Transcutaneous
By Indication
- Jaundice
- Hepatitis
By Age Group
- Neonatal
- Adults
By End User
- Hospitals and Nursing Home
- Clinics
- Others
Key Market Players
- APEL Co. Ltd
- Dragerwerk AG & Co. KGaA
- Mennen Medical Ltd
- Micro Lab Instruments
- Ningbo David Medical Device Co. Ltd
- Siemens Healthineers AG
- Micro Labs Instruments
- AVI Healthcare Pvt Ltd
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: BILIRUBIN METERS MARKET, BY PRODUCT
CHAPTER 5: BILIRUBIN METERS MARKET, BY INDICATION
CHAPTER 6: BILIRUBIN METERS MARKET, BY AGE GROUP
CHAPTER 7: BILIRUBIN METERS MARKET, BY END USER
CHAPTER 8: BILIRUBIN METERS MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- APEL Co. Ltd
- Dragerwerk AG & Co. KGaA
- Mennen Medical Ltd
- Micro Lab Instruments
- Ningbo David Medical Device Co. Ltd
- Siemens Healthineers AG
- Micro Labs Instruments
- AVI Healthcare Pvt Ltd
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 1.2 billion |
| Forecasted Market Value ( USD | $ 2.5 billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
